Ckd clinical trials

Explore recruiting ckd clinical trials.

Recruiting ckd studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Ckd trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Albuminuria Reduction Trial and Investigation with Survodutide Treatment in CKD (ARTIST-CKD)

Germany, Spain, Netherlands

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase 3, Open-label, Uncontrolled Study to Evaluate the Activity, Safety, Pharmacokinetics and Pharmacodynamics of Roxadustat for the Treatment of Anemia in Pediatric Participants with Chronic Kidney Disease

Slovakia, Germany, Denmark, Italy, Belgium, Norway +14 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

I8F-MC-GPIG - Tirzepatide Study of Renal Function in People with Overweight or Obesity and Chronic Kidney Disease with or without Type 2 Diabetes: Focus on Kidney Hypoxia in Relation to Fatty Kidney Disease using Multiparametric Magnetic Resonance Imaging (TREASURE-CKD)

Denmark, Austria, Netherlands

Therapeutic exploratory (Phase II) EU CTIS Study details

Efficiency of everolimus for the treatment of kidney transplanted patients presenting a missing self-induced NK-mediated rejection (STARR)

France

Therapeutic use (Phase IV) EU CTIS Study details

A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Atrasentan in Patients with IgA Nephropathy at Risk of Progressive Loss of Renal Function (The ALIGN Study)

Germany, Portugal, Italy, Spain, France, Poland

Therapeutic confirmatory (Phase III) EU CTIS Study details

A randomized, controlled study to evaluate LNP023 (iptacopan) in patients with active ANCA-associated vasculitis.

Hungary, Denmark, Austria, Netherlands, Spain, Germany +3 more

Therapeutic exploratory (Phase II) EU CTIS Study details

Ckd trials by city

Ckd in Toronto Ckd in Vancouver Ckd in Montreal Ckd in Calgary Ckd in Edmonton Ckd in Ottawa Ckd in Winnipeg Ckd in Quebec City Ckd in Hamilton Ckd in Kitchener Ckd in London Ckd in Halifax Ckd in New York Ckd in Los Angeles Ckd in Chicago Ckd in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease